Jeffrey Jacques

As chief medical officer at Virgin Pulse, Dr. Jacques is tasked with advancing the company's clinical strategy, providing insight and guidance to product and commercial teams.

Dr. Jacques joined Virgin Pulse with more than 20 years of experience in digital health, population health management, and advanced clinical analytics, developing solutions that support individuals and populations through complex health journeys. He was previously CEO and co-founder of CareTribe, a digital health platform dedicated to supporting the needs of family caregivers. It was acquired by family support company Cleo in 2022, where he became chief strategy officer. He also held leadership roles with CVS Health/Aetna for more than a decade, including as the founder of NeoCare Solutions, a CVS Health/Aetna business supporting the parents of premature infants in the NICU, and as chief clinical innovation officer at ActiveHealth Management, a CVS Health company focused on population health.